Objective Capital Management’s Amgen AMGN Stock Holding History

Objective Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$237K	Hold	562	–	–	0.21%	87
2026 Q2	$204K	Buy	+562	New	+$192K	0.18%	96
2025 Q1	–	Sell	-1,098	Closed	-$286K	–	80
2024 Q4	$286K	Sell	1,098 -277	-20%	-$82.2K	0.19%	105
2024 Q3	$443K	Buy	+1,375	New	+$450K	0.26%	85
2024 Q1	$241K	Buy	848 +9	+1%	+$2.63K	0.16%	118
2023 Q4	$242K	Buy	839 +1	+0.1%	+$272	0.18%	102
2023 Q3	$225K	Buy	+838	New	+$209K	0.2%	91
2023 Q2	–	Sell	-871	Closed	-$211K	–	99
2023 Q1	$211K	Buy	+871	New	+$214K	0.19%	91

Other funds holding AMGN

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Smead Capital Management Phoenix, Arizona $4.71B AUM 32.07% 1-Year Est. Return

Forum Financial Management Lombard, Illinois $7.7B AUM 11.59% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.8B AUM 30.39% 1-Year Est. Return

OpenArc Corporate Advisory Atlanta, Georgia $8.86B AUM 19.31% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Objective Capital Management's AMGN Position: Q3 2026 in Review

Objective Capital Management held its Amgen (AMGN) position steady in Q3 2026 at 562 shares worth $237K. The position accounts for 0.21% of the portfolio, ranked #87.

Objective Capital Management first reported a position in AMGN in Q1 2023 and has held it in 8 quarters since. The position peaked at $443K in Q3 2024. 876 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

Objective Capital Management held 562 shares of Amgen worth $237K as of Q3 2026.
Objective Capital Management left its Amgen share count unchanged in Q3 2026.
Amgen made up 0.21% of Objective Capital Management's portfolio in Q3 2026, its #87 holding.
Objective Capital Management first reported a position in Amgen in Q1 2023 and has held it in 8 quarters since.
Objective Capital Management's Amgen position peaked at $443K in Q3 2024.
876 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Objective Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.